Recent findings have expanded the use of Bruton tyrosine kinase (BTK) inhibitors for use in combination therapy that has resulted in improved progression-free survival (PFS). Data has emerged stratifying the use of BTK inhibitors in combination with autologous stem cell transplant. These data were presented at major medical conferences in 2022.
Tip sheet to provide a snapshot of the latest information regarding treatment options for patients with MCL, especially with R/R disease.
The document provides an overview of R/R MCL, including its nature, symptoms, treatment options (FDA-approved drugs, stem cell transplants), investigational treatments in clinical trials, and the importance of regular follow-ups and clinical trial participation.
ACS offers comprehensive information on various cancers, including B-cell non-Hodgkin lymphomas (such as mantle cell lymphoma). Their website provides educational resources for patients and caregivers that review treatment options, side effect management, and support services.
The Clinical Trial Support Center (CTSC) features a nurse clinician who can assist lymphoma patients with identifying clinical trial opportunities for which they may be eligible. LLS is a nonprofit organization focused on funding research and providing support to patients with blood cancers, including lymphomas.
An educational booklet published by LLS that discusses topics relevant to non-Hodgkin lymphomas (such as mantle cell lymphoma). Topics include diagnosis, staging, treatment options, side effect management, financial concerns, and resources for support. LLS is a nonprofit organization focused on funding research and providing support to patients with hematological cancers such as MCL.
The LLS online social network connects people who are living with or supporting someone who has a blood cancer. Members will find the following: thousands of patients and caregivers sharing experiences and information, support from knowledgeable staff, ongoing and accurate disease updates, as well as the opportunity to participate in surveys to improve cancer care.
The document provides an overview of autologous chimeric antigen receptor (CAR) T-cell therapy for hematologic malignancies, detailing development, clinical applications, efficacy, risks, and the complexities of integrating this personalized treatment into clinical practice.
A place for patients to share personal stories, inspiration, and updates with other patients and caregivers who are navigating cancer in their own lives or are working to make a positive difference for people who have been impacted by a cancer diagnosis.
The Lymphoma Support Community connects patients and caregivers affected by lymphoma and encourages them to share their personal stories and learn from one another as well as from educational resources provided.
CancerCare provides free, professional support services for people affected by mantle cell lymphoma, guided by oncology-specific social workers. Patient education, treatment information, support groups, financial assistance, counseling, and additional resources are available.
In this video, William B Pearse, MD, discusses advancements in the treatment of relapsed/refractory mantle cell lymphoma, highlighting the integration of Bruton tyrosine kinase (BTK) inhibitors into frontline therapy, supported by findings from the ongoing phase 3 TRIANGLE study.